Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Chronic spontaneous urticaria
Economic impact of Chronic spontaneous urticaria on families
3 evidence topics · 3 sources
Family quality of life and household expenses by disease activity and control, international UCARE study
“This international cross‐sectional study was conducted in 12 countries across three continents, from January to December 2024 at Urticaria Centres of Reference and Excellence (UCARE).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“A total of 1187 CSU patients and their respective family members completed questionnaires, including the Family Dermatology Life Quality Index (FDLQI), and physicians also provided clinical data on disease severity and control.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“FDLQI had a mean total score of 9.6 and mean scores varied across countries (Figure 1, Table S1).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“When stratified by UAS7 severity (minimal activity, mild, moderate, severe), family members of patients with higher disease activity reported significantly greater emotional distress, physical burden, social limitations and financial strain (Figure 3, Table S2).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Household expenses showed no statistically significant association with either severity (β = 0.27; CI95% –0.47 to 1.00) or control (β = −0.23; CI95% –0.53 to 0.06).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Healthcare costs in Medicaid-enrolled children younger than 12 years
“Medicaid claims from four states (09/01/2013–03/31/2016) were used to identify patients less than 12 years old.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“A total of 548 CIU/CSU patients (mean [SD] age 4.5 [3.3] years; 51.3% male) were matched 1:1 with controls.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Moreover, CIU/CSU patients also had significantly higher PPPY healthcare costs (mean cost difference [MCD] $1853), driven by incremental outpatient (MCD $1286) costs (all p values < 0.01).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“CIU/CSU adversely affects lives of pediatric patients and their caregivers, leading to school absenteeism, reduced school performance, and more days off work [9].” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Healthcare costs in commercially insured children younger than 12 years
“To describe treatment patterns, health care resource utilization (HRU), and costs in pediatric patients with CIU/CSU (<12 years old) and to compare these with pediatric patients without CIU/CSU.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“A commercial administrative claims data base (September 2013 to June 2016) was used.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“A total of 6109 pediatric patients with CIU/CSU were selected, and 6107 were 1:1 matched with controls.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Relative to the controls, the patients with CIU/CSU had higher rates of HRU (incidence rate ratios of 1.71, 2.39, and 2.07 for inpatient, emergency department, and outpatient visits, respectively; all p < 0.01), and higher all-cause per patient per year costs (mean cost differences of $2090, $1606, and $483 for total, medical, and pharmacy costs, respectively; all p < 0.01).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote